We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery?

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00547989
First Posted: October 23, 2007
Last Update Posted: June 11, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Maastricht University Medical Center
October 18, 2007
October 23, 2007
June 11, 2014
October 2006
December 2010   (Final data collection date for primary outcome measure)
reduction of unplanned admissions and reduction of VAS score. [ Time Frame: one week ]
Same as current
Complete list of historical versions of study NCT00547989 on ClinicalTrials.gov Archive Site
to determine the safety and performance (efficacy) of the technique and the investigational product. [ Time Frame: one week ]
Same as current
Not Provided
Not Provided
 
Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery?
Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery?
Aim is to study if a paravertebral block as an adjunct to general anesthesia is a suitable technique for extended, one sided, breast surgery.

Usually breast tumour surgery in the Academic Hospital Maastricht is performed under general anaesthesia. Perioperative pain management consists of paracetamol and naproxen preoperatively, opioids during surgery and local wound infiltration at the end of surgery with 10cc Bupivacaine 0.25%. Postoperative pain management consists of paracetamol, occasionally combined with Naproxen, and if necessary Piritramide 0.2 mg/kg i.m.

Alternatively there is the possibility to perform breast surgery under a thoracic paravertebral block (PVB) with or without general anesthesia.

A PVB according to Eason and Wyatt (1) can be performed preoperatively with insertion of an end-hole catheter T3-T4. With this technique we expect a better pain relief postoperatively.

Interventional
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Breast Cancer
  • Drug: standard anaesthesia (bupivacaine)
    Local infiltration with bupivacaine and Piritramide and Paracetamol as postoperative analgesic, and ondansetron as required
  • Drug: additional pvb (ropivacaine) and elastomeric disposable infusion pump
    Patients in group 2 will receive PVB with ropivacaine and postoperative pump 5ml/h.
  • Drug: additional pvb (ropivacaine)
    Patients in group 1 will receive PVB with ropivacaine
  • Active Comparator: 1
    control
    Intervention: Drug: standard anaesthesia (bupivacaine)
  • Experimental: 2
    PVB with ropivacaine and postoperative pump 5ml/h
    Intervention: Drug: additional pvb (ropivacaine) and elastomeric disposable infusion pump
  • Experimental: Experimental 1
    PVB with ropivacaine, 10 patients included but not analysed
    Intervention: Drug: additional pvb (ropivacaine)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
46
May 2011
December 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Extended mamma surgery one-sided
  • ASA class I and II

Exclusion Criteria:

  • All contra indications for local anaesthesia
  • Coagulation disorders
  • Infection
  • Allergic reactions
Sexes Eligible for Study: Female
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Netherlands
 
 
NCT00547989
MEC 05-105.5
No
Not Provided
Not Provided
Maastricht University Medical Center
Maastricht University Medical Center
Not Provided
Principal Investigator: Esther Bouman, MD azM
Maastricht University Medical Center
June 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP